Search - tctmd.com

Displaying 261 - 280 of 463

Sort: Relevancy | Date

Presentation TCT 2016

Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness?

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Justin E. Davies

October 30, 2016

Presentation TCT 2016

Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Kona WAVE IV Trial

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Roland E Schmieder

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Laura Mauri

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, William B. White

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Bryan Williams

October 30, 2016

Presentation TCT 2016

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Horst Sievert

October 30, 2016

Presentation TCT 2016

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Felix Mahfoud

October 30, 2016

Presentation TCT 2016

Hypertension Treatment Targets Beyond the Kidneys

Presenter: Felix Mahfoud, Michael A. Weber, Atul Pathak

October 30, 2016

Presentation TCT 2016

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Presenter: Felix Mahfoud, Michael A. Weber, Michael Joner

October 30, 2016

Presentation TCT 2016

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Presenter: Felix Mahfoud, Michael A. Weber, Ehtisham Mahmud

October 30, 2016

Presentation TCT 2016

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Presenter: Felix Mahfoud, Michael A. Weber

October 30, 2016

Presentation TCT 2016

Using Virtual Reality in Interventional Cardiology

Presenter: Oscar A. Mendiz, Giora Weisz, Silvio J. Bezerra

October 30, 2016

Presentation TCT 2016

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Presenter: Oscar A. Mendiz, Giora Weisz, Caterina Gandolfo

October 30, 2016

Presentation TCT 2016

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

Presenter: Oscar A. Mendiz, Giora Weisz, Philipp Lurz

October 30, 2016

Presentation TCT 2016

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Presenter: Oscar A. Mendiz, Giora Weisz, Horst Sievert

October 30, 2016

Presentation

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Presenter: James P. Howard

January 11, 2016

Presentation TCT 2015

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

Presenter: Greg L. Kaluza, Joachim Schofer, Richard R. Heuser

October 15, 2015

Advertisement

Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness?

Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial

Device Overview and Ongoing Study Design: Kona WAVE IV Trial

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Hypertension Treatment Targets Beyond the Kidneys

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Using Virtual Reality in Interventional Cardiology

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content